Napp Pharmaceuticals

Napp Pharmaceuticals is part of a worldwide association of independent pharmaceutical companies that have been developing vital new drugs for more than half a century. Napp pioneered the creation of prolonged release drugs, particularly for the relief of severe pain. Its development of controlled-release morphine sulphate tablets (MST® Continus® tablets) was a world first, and it now produces 18 analgesics in 52 different formulations. Napp also produces a number of other medicines for the treatment of cardiovascular disease, respiratory disease and gastrointestinal problems. The company moved to the prestigious Cambridge Science Park in the early 1980s, opening its striking UK headquarters building in 1983. The success of its research and sales operations has seen the number of employees grow to more than 800, and Napp's facilities have expanded into three other buildings on the Science Park. Napp's sales have grown significantly and it is now rated 18th by size of prescription-only medicine sales among 230 companies in the UK pharmaceutical industry.